Riskpilot← Back to searchSign inGet full accessSurgify Medical Oy
OYActiveY-tunnus 2828662-9Otakaari 5Manufacture of medical and dental instruments and supplies · NACE 3250Est. 2017— employeessurgifymedical.com
Revenue 2024
EUR 95K
+143% vs 2023
EBITDA margin
-1489.2%
-129% vs 2023
Equity ratio
-155.6%
Financial strength
Net profit 2024
EUR -1,6M
-83% vs 2023
| Revenue | EUR 95K | +143% |
| EBITDA | EUR -1,4M | -129% |
| Net profit | EUR -1,6M | -83% |
| Total assets | EUR 2M | -32% |
| Equity | EUR -3,1M | -113% |
| Employees | — | — |
Legal name
Surgify Medical Oy
Y-tunnus number
2828662-9
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
12. huhtikuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on lääkintä- ja hammaslääkintäinstrumenttien ja -tarvikkeiden valmistus, kehittäminen ja myynti sekä niihin liittyvät palvelut. Yhtiö voi ostaa ja myydä arvopapereita sekä omistaa ja hallita rakennuksia, asunto-osakkeita, maa-alueita sekä kiinteää omaisuutta.
Address
Otakaari 5
Website
surgifymedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 8 | 39 | 95 |
| Staff expenses | −121 | −139 | −306 | −810 | −1 089 |
| EBITDA | −272 | −310 | −578 | −615 | −1 411 |
| Depreciation & amort. | −313 | −417 | −478 | −198 | −180 |
| EBIT | −585 | −727 | −1 057 | −813 | −1 590 |
| Net financials | −10 | −16 | −16 | −72 | −28 |
| Profit before tax | −595 | −743 | −1 072 | −886 | −1 618 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −595 | −743 | −1 072 | −886 | −1 618 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 378 | 2 065 | 2 131 | 2 885 | 1 963 |
| Equity | 1 265 | 522 | 459 | −1 437 | −3 055 |
| Long-term debt | 1 024 | 1 402 | 1 453 | 3 463 | 1 215 |
| Short-term debt | 89 | 141 | 219 | 859 | 3 802 |
| Total debt | 1 113 | 1 543 | 1 672 | 4 321 | 5 017 |
EBITDA margin
-1489.2%
This company
15.8%
Market median
-9525% vs market
20202024
Equity ratio
-155.6%
This company
38.2%
Market median
-507% vs market
20202024
Return on equity
-161804900.0%
This company
18.4%
Market median
-879374557% vs market
20202024
Net profit margin
-1708.4%
This company
8.1%
Market median
-21191% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
1.64×
This company
0.62×
Market median
-165% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VR Chief Executive Officer | Chief Executive Officer | 2017 |
| Former (1) | ||
PM | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairperson | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2018 | |
| Board of Directors | 2020 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Chairperson | 2021 – 2024 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Surgify Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Magnus Granholm | Audit | 0 companies |
| Visa Robert Sippola | Chief Executive Officer | 0 companies |
| Alan Henry Raffensperger | Chairperson | 0 companies |
| Alex René Giltaij | Chairperson | 0 companies |
| Seyedshahabaddin Najafi Haeri | Board of Directors | 0 companies |
| Jan Petri Ekström | Board of Directors | 0 companies |
| Juho Ilmari Risku | Board of Directors | 0 companies |
| Adriaan Heert Johannes Hart de Ruijter | Board of Directors | 0 companies |
| Magnus Andreas Bunge | Board of Directors | 0 companies |
| Thomas Rainer Prischenk | Board of Directors | 0 companies |